Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080474 | SCV000112376 | benign | not specified | 2013-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080474 | SCV000235830 | benign | not specified | 2014-11-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000080474 | SCV000268948 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Ser666Leu in exon 17 of DMD: This variant is not expected to have clinical sig nificance because it has been identified in 1.6% (61/3833) of African American c hromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/E VS/; dbSNP rs34563188). |
Labcorp Genetics |
RCV001084848 | SCV000288047 | benign | Duchenne muscular dystrophy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000250691 | SCV000319108 | benign | Cardiovascular phenotype | 2015-04-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000711450 | SCV000603366 | benign | not provided | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711450 | SCV000841817 | benign | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000853044 | SCV000995801 | benign | Cardiomyopathy | 2019-02-16 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001165928 | SCV001328186 | uncertain significance | Dilated cardiomyopathy 3B | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080474 | SCV004038128 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000711450 | SCV001932818 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000080474 | SCV001975493 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826731 | SCV002092201 | benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-04-11 | no assertion criteria provided | clinical testing |